摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3,3,5,5-tetramethylcyclohexyl)phenylamine oxalic acid salt | 915769-95-8

中文名称
——
中文别名
——
英文名称
2-(3,3,5,5-tetramethylcyclohexyl)phenylamine oxalic acid salt
英文别名
2-(3,3,5,5-tetramethylcyclohexyl)phenylamine oxalate;2-(3,3,5,5-Tetramethylcyclohexyl)phenylamine oxalate;oxalic acid;2-(3,3,5,5-tetramethylcyclohexyl)aniline
2-(3,3,5,5-tetramethylcyclohexyl)phenylamine oxalic acid salt化学式
CAS
915769-95-8
化学式
C2H2O4*C16H25N
mdl
——
分子量
321.417
InChiKey
NVDPXGIZIFLQEC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.74
  • 重原子数:
    23
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    101
  • 氢给体数:
    3
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    2-(3,3,5,5-tetramethylcyclohexyl)phenylamine oxalic acid salt氢氧化钾 作用下, 以 甲苯 为溶剂, 反应 0.5h, 以98.8%的产率得到2-(3,3,5,5-tetramethylcyclohexyl)phenylaniline
    参考文献:
    名称:
    WO2006/126635
    摘要:
    公开号:
  • 作为产物:
    描述:
    2-(3,3,5,5-tetramethylcyclohexyl)phenylaniline草酸正庚烷乙酸乙酯 为溶剂, 反应 66.0h, 以to give 4.13 g of the title compound as white crystals的产率得到2-(3,3,5,5-tetramethylcyclohexyl)phenylamine oxalic acid salt
    参考文献:
    名称:
    Intermediate in Production of [2-(3,3,5,5-Tetramethylcyclohexyl)phenyl]Piperazine Compound
    摘要:
    下列一般公式所代表的化合物或其盐,在制备具有优异细胞黏附抑制作用和细胞侵袭抑制作用的[2-(3,3,5,5-四甲基环己基)苯基]哌嗪化合物的过程中,作为有用的中间体。因此,该化合物可用作治疗或预防各种由白细胞黏附和侵袭引起的炎症性疾病和自身免疫性疾病的药物,如炎症性肠病(尤其是溃疡性结肠炎或克罗恩病)、肠易激综合征、类风湿性关节炎、银屑病、多发性硬化症、哮喘和特应性皮炎。其中,R1和R2分别表示氢或氨基保护基,或R1和R2结合形成可选取代的吡咯环。
    公开号:
    US20090163715A1
点击查看最新优质反应信息

文献信息

  • 1,2-di(cyclic) substituted benzene compounds
    申请人:Kawahara Tetsuya
    公开号:US20060276465A1
    公开(公告)日:2006-12-07
    A compound represented by the following general formula (1) or (100), a salt thereof or a hydrate of the foregoing has excellent cell adhesion inhibitory action or cell infiltration inhibitory action, and is useful as a therapeutic or prophylactic agent for various inflammatory diseases and autoimmune diseases associated with adhesion and infiltration of leukocytes, such as inflammatory bowel disease (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma and atopic dermatitis. wherein R 10 represents optionally substituted cycloalkyl, etc., R 20-23 represent hydrogen, alkyl, alkoxy, etc., R 30-32 represent hydrogen, alkyl, oxo, etc., and R40 represents optionally substituted alkyl, etc. And A compound represented by the following general formula (1) or (100), a salt thereof or a hydrate of the foregoing has excellent cell adhesion inhibitory action or cell infiltration inhibitory action, and is useful as a therapeutic or prophylactic agent for various inflammatory diseases and autoimmune diseases associated with adhesion and infiltration of leukocytes, such as inflammatory bowel disease (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma and atopic dermatitis. wherein R 10 represents 5- to 10-membered cycloalkyl etc. optionally substituted with hydroxyl etc., R 30 , R 31 and R 32 may be the same or different and each represents hydrogen etc., R 40 represents C1-10 alkyl etc. optionally substituted with hydroxyl etc., n represents an integer of 0, 1 or 2, X 1 represents CH or nitrogen, and R 20 , R 21 , R 22 and R 23 may be the same or different and each represents hydrogen etc.
    以下通式(1)或(100)所代表的化合物,其盐或水合物,具有优良的细胞黏附抑制作用或细胞浸润抑制作用,可用作治疗或预防与白细胞黏附和浸润相关的各种炎症性疾病和自身免疫疾病的药物,例如炎症性肠病(特别是溃疡性结肠炎或克罗恩病)、肠易激综合症、类风湿性关节炎、牛皮癣、多发性硬化症、哮喘和特应性皮炎。其中,R10表示可选取代的环烷基等,R20-23表示氢、烷基、烷氧基等,R30-32表示氢、烷基、氧代等,R40表示可选取代的烷基等。另外,以下通式(1)或(100)所代表的化合物,其盐或水合物,具有优良的细胞黏附抑制作用或细胞浸润抑制作用,可用作治疗或预防与白细胞黏附和浸润相关的各种炎症性疾病和自身免疫疾病的药物,例如炎症性肠病(特别是溃疡性结肠炎或克罗恩病)、肠易激综合症、类风湿性关节炎、牛皮癣、多发性硬化症、哮喘和特应性皮炎。其中,R10表示5-到10-成员环烷基等,可选取代为羟基等,R30、R31和R32可以相同也可以不同,每个表示氢等,R40表示可选取代的C1-10烷基等,可选取代为羟基等,n表示0、1或2,X1表示CH或氮,R20、R21、R22和R23可以相同也可以不同,每个表示氢等。
  • Crystal and Salt of 1-Cyclopropylmethyl-4-[2-(3,3,5,5-Tetramethylcyclohexyl)Phenyl]Piperazine
    申请人:Kotake Makoto
    公开号:US20080161566A1
    公开(公告)日:2008-07-03
    Salts and crystals of 1-cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine have excellent cell adhesion inhibitory action and cell infiltration inhibitory action, and are useful as therapeutic or prophylactic agents for various inflammatory diseases and autoimmune diseases associated with adhesion and infiltration of leukocytes, such as inflammatory bowel disease (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma and atopic dermatitis.
    1-环丙基甲基-4-[2-(3,3,5,5-四甲基环己基)苯基]哌嗪的盐和晶体具有极好的细胞黏附抑制作用和细胞浸润抑制作用,可用作治疗或预防与白细胞黏附和浸润有关的各种炎症性疾病和自身免疫性疾病的药物,例如炎症性肠病(尤其是溃疡性结肠炎或克罗恩病)、肠易激综合征、类风湿性关节炎、银屑病、多发性硬化症、哮喘和特应性皮炎。
  • Intermediate in Production of [2-(3,3,5,5-Tetramethylcyclohexyl)phenyl]Piperazine Compound
    申请人:Nagai Mitsuo
    公开号:US20090163715A1
    公开(公告)日:2009-06-25
    A compound represented by the general formula below or a salt thereof is a useful intermediate in the production of a [2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine compound that has excellent cell adhesion inhibitory effect and cell invasion inhibitory effect and therefore is useful as a therapeutic or prophylactic agent for various inflammatory diseases and autoimmune diseases induced by the adhesion and invasion of leukocytes, such as inflammatory bowel diseases (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma and atopic dermatitis. wherein R 1 and R 2 independently represent hydrogen or a protecting group for an amino group, or R 1 and R 2 bond together to form an optionally substituted pyrrole ring.
    下列一般公式所代表的化合物或其盐,在制备具有优异细胞黏附抑制作用和细胞侵袭抑制作用的[2-(3,3,5,5-四甲基环己基)苯基]哌嗪化合物的过程中,作为有用的中间体。因此,该化合物可用作治疗或预防各种由白细胞黏附和侵袭引起的炎症性疾病和自身免疫性疾病的药物,如炎症性肠病(尤其是溃疡性结肠炎或克罗恩病)、肠易激综合征、类风湿性关节炎、银屑病、多发性硬化症、哮喘和特应性皮炎。其中,R1和R2分别表示氢或氨基保护基,或R1和R2结合形成可选取代的吡咯环。
  • CRYSTAL AND SALT OF 1-CYCLOPROPYLMETHYL-4-Ý2-(3,3,5,5)-TETRAMETHYLCYCLOHEXYL)PHENYL¨PIPERAZINE
    申请人:Eisai R&D Management Co., Ltd.
    公开号:EP1832580A1
    公开(公告)日:2007-09-12
    Salts and crystals of 1-cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine have excellent cell adhesion inhibitory action and cell infiltration inhibitory action, and are useful as therapeutic or prophylactic agents for various inflammatory diseases and autoimmune diseases associated with adhesion and infiltration of leukocytes, such as inflammatory bowel disease (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma and atopic dermatitis.
    1- 环丙基甲基-4-[2-(3,3,5,5-四甲基环己基)苯基]哌嗪的盐类和晶体具有极佳的细胞粘附抑制作用和细胞浸润抑制作用,可用作与白细胞粘附和浸润有关的各种炎症性疾病和自身免疫性疾病的治疗剂或预防剂、如炎症性肠病(特别是溃疡性结肠炎或克罗恩病)、肠易激综合征、类风湿性关节炎、银屑病、多发性硬化症、哮喘和特应性皮炎。
  • INTERMEDIATE IN PRODUCTION OF [2-(3,3,5,5-TETRAMETHYLCYCLOHEXYL)PHENYL]PIPERAZINE COMPOUND
    申请人:Eisai R&D Management Co., Ltd.
    公开号:EP1889827A1
    公开(公告)日:2008-02-20
    A compound represented by the general formula below or a salt thereof is a useful intermediate in the production of a [2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine compound that has excellent cell adhesion inhibitory effect and cell invasion inhibitory effect and therefore is useful as a therapeutic or prophylactic agent for various inflammatory diseases and autoimmune diseases induced by the adhesion and invasion of leukocytes, such as inflammatory bowel diseases (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma and atopic dermatitis. wherein R1 and R2 independently represent hydrogen or a protecting group for an amino group, or R1 and R2 bond together to form an optionally substituted pyrrole ring.
    下式通式所代表的化合物或其盐是生产[2-(3,3,5,5-四甲基环己基)苯基]哌嗪化合物的有用中间体,该化合物具有极佳的细胞粘附抑制作用和细胞侵袭抑制作用,因此可用作由白细胞粘附和侵袭诱发的各种炎症性疾病和自身免疫性疾病的治疗剂或预防剂、如炎症性肠病(特别是溃疡性结肠炎或克罗恩病)、肠易激综合征、类风湿性关节炎、银屑病、多发性硬化症、哮喘和特应性皮炎。 其中 R1 和 R2 独立地代表氢或氨基的保护基团,或 R1 和 R2 键合形成任选取代的吡咯环。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐